Form 4 for CLMT Calumet, Inc. /DE
Accepted 2024-07-12 00:00:00 ET · period of report 2024-07-10 · accession 0000950170-24-083330 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-12 | 2024-07-10 | CLMT | Heritage Group | 10%, 13(d) 10% Group Member | J - Other | — | +2.81M | 12.59M | +29% | — |
| D | 2024-07-12 | 2024-07-10 | CLMT | Heritage Group | 10%, 13(d) 10% Group Member | J - Other | — | +1.02M | 1.02M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 per share | 2024-07-10 | J | A | 2,805,000 | — | 12,587,209 | D | — | — | (F1) On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC ("Merger Sub I") merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). Pursuant to the GP Merger, all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Calumet, Inc. common stock, par value $0.01 per share (the "Common Stock"), and 2,000,000 warrants to purchase Common Stock (the "Warrants"). In connection with the GP Merger, the reporting person was issued 2,805,000 shares of Common Stock and 1,020,000 Warrants. |
| 2 | Derivative | Warrants to purchase Common Stock | 2024-07-10 | J | A | 1,020,000 | — | 1,020,000 | D | $20.00 · 2024-07-10 to 2027-07-10 | 1,020,000 Common Stock, par value $0.01 per share | (F1) On July 10, 2024, in connection with the corporate reorganization of Calumet Specialty Products Partners, L.P. (the "Partnership"), pursuant to which the Partnership converted from a master limited partnership to a corporation (the "Conversion"), Calumet Merger Sub I LLC ("Merger Sub I") merged with and into Calumet GP, LLC, the general partner (the "General Partner") of the Partnership, with the General Partner continuing as the surviving entity and a wholly owned subsidiary of Calumet, Inc. (the "GP Merger"). Pursuant to the GP Merger, all outstanding equity interests of the General Partner were exchanged into the right to receive an aggregate of 5,500,000 shares of Calumet, Inc. common stock, par value $0.01 per share (the "Common Stock"), and 2,000,000 warrants to purchase Common Stock (the "Warrants"). In connection with the GP Merger, the reporting person was issued 2,805,000 shares of Common Stock and 1,020,000 Warrants. |